Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer

Hepatocellular carcinoma (HCC) is the primary form of liver cancer and a major cause of cancer death worldwide. Early detection is key to effective treatment. Yet, early diagnosis is challenging, especially in patients with cirrhosis, who are at high risk of developing HCC. Dysfunction or loss of fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaidi, Sobia, Amdur, Richard, Xiang, Xiyan, Yu, Herbert, Wong, Linda L., Rao, Shuyun, He, Aiwu R., Amin, Karan, Zaheer, Daewa, Narayan, Raj K., Satapathy, Sanjaya K., Latham, Patricia S., Shetty, Kirti, Guha, Chandan, Gough, Nancy R., Mishra, Lopa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170384/
https://www.ncbi.nlm.nih.gov/pubmed/35677836
http://dx.doi.org/10.18632/genesandcancer.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170384/
https://www.ncbi.nlm.nih.gov/pubmed/35677836
http://dx.doi.org/10.18632/genesandcancer.220

Ejemplares similares